全文获取类型
收费全文 | 22904篇 |
免费 | 1667篇 |
国内免费 | 93篇 |
专业分类
耳鼻咽喉 | 240篇 |
儿科学 | 606篇 |
妇产科学 | 594篇 |
基础医学 | 2788篇 |
口腔科学 | 483篇 |
临床医学 | 2446篇 |
内科学 | 4415篇 |
皮肤病学 | 324篇 |
神经病学 | 2348篇 |
特种医学 | 782篇 |
外国民族医学 | 3篇 |
外科学 | 3902篇 |
综合类 | 275篇 |
一般理论 | 16篇 |
预防医学 | 1803篇 |
眼科学 | 521篇 |
药学 | 1632篇 |
中国医学 | 14篇 |
肿瘤学 | 1472篇 |
出版年
2023年 | 109篇 |
2022年 | 190篇 |
2021年 | 407篇 |
2020年 | 258篇 |
2019年 | 424篇 |
2018年 | 539篇 |
2017年 | 403篇 |
2016年 | 422篇 |
2015年 | 500篇 |
2014年 | 683篇 |
2013年 | 997篇 |
2012年 | 1584篇 |
2011年 | 1647篇 |
2010年 | 908篇 |
2009年 | 764篇 |
2008年 | 1496篇 |
2007年 | 1724篇 |
2006年 | 1499篇 |
2005年 | 1487篇 |
2004年 | 1530篇 |
2003年 | 1313篇 |
2002年 | 1310篇 |
2001年 | 247篇 |
2000年 | 235篇 |
1999年 | 256篇 |
1998年 | 289篇 |
1997年 | 245篇 |
1996年 | 196篇 |
1995年 | 169篇 |
1994年 | 162篇 |
1993年 | 155篇 |
1992年 | 161篇 |
1991年 | 154篇 |
1990年 | 128篇 |
1989年 | 110篇 |
1988年 | 101篇 |
1987年 | 115篇 |
1986年 | 112篇 |
1985年 | 85篇 |
1984年 | 101篇 |
1983年 | 108篇 |
1982年 | 102篇 |
1981年 | 111篇 |
1980年 | 85篇 |
1979年 | 76篇 |
1978年 | 77篇 |
1976年 | 77篇 |
1975年 | 74篇 |
1973年 | 73篇 |
1972年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Martin R. Späth Malte P. Bartram Nicolàs Palacio-Escat K. Johanna R. Hoyer Cedric Debes Fatih Demir Christina B. Schroeter Amrei M. Mandel Franziska Grundmann Giuliano Ciarimboli Andreas Beyer Jayachandran N. Kizhakkedathu Susanne Brodesser Heike Göbel Jan U. Becker Thomas Benzing Bernhard Schermer Martin Höhne Markus M. Rinschen 《Kidney international》2019,95(2):333-349
3.
4.
5.
Keith P. Reber John D. Sivey Matthew Vollmuth Priyansh D. Gujarati 《Journal of labelled compounds & radiopharmaceuticals》2022,65(9):254-263
Parabens are antimicrobial additives found in a wide array of consumer products. However, the halogenated compounds formed from parabens during wastewater disinfection are a potential environmental concern. In order to identify these transformation products and investigate their mechanism of formation, a synthetic route to ethyl parabens labeled with the stable isotope carbon-13 at specific positions within the benzene ring was developed. This efficient two-step procedure starts from commercially available 13C-labeled phenols and involves (1) initial acylation of the phenol via a Houben–Hoesch reaction with trichloroacetonitrile followed by (2) a modified haloform reaction of the resulting trichloromethyl ketone to afford the corresponding 13C-labeled ethyl parabens in 65%–80% overall yield. The scope of the modified haloform reaction was also investigated, allowing for the synthesis of other parabens derived from primary or secondary alcohols, including 13C- and deuterium-labeled esters. In addition, 4-hydroxybenzoic acid can be formed directly from the common trichloromethyl ketone intermediate upon treatment with lithium hydroxide. This protocol complements existing methods for preparing 13C-labeled paraben derivatives and offers the specific advantages of exhibiting complete regioselectivity in the Houben–Hoesch reaction (to form the para-disubstituted product) and avoiding the need for protecting groups in the modified haloform reaction that forms the paraben esters. 相似文献
6.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
7.
8.
Fluid role boundaries: exploring the contribution of the advanced nurse practitioner to multi‐professional palliative care
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
9.
Christopher J. Destache David J. Guervil Keith S. Kaye 《International journal of antimicrobial agents》2019,53(5):644-649
Background
The clinical experience of ceftaroline fosamil (CPT-F) therapy for Gram-positive infective endocarditis is reported from CAPTURE, a retrospective study conducted in the USA.Methods
Data, including patient demographics, medical history, risk factors, microbiological aetiology and clinical outcomes, were collected by review of patient charts between September 2013 and February 2015.Results
Patients (n=55) with Gram-positive endocarditis were treated with CPT-F. The most common risk factors were intravascular devices (43.6%), diabetes mellitus (40.0%) and injection drug use (38.2%). The most commonly isolated pathogens were meticillin-resistant Staphylococcus aureus (MRSA; 80%), meticillin-susceptible S. aureus (MSSA; 7.3%) and coagulase-negative staphylococci (7.3%). CPT-F was given as first-line therapy in 7.3% of patients and as second-line or later therapy in 92.7% of patients, and as monotherapy in 41.8% of patients and as concurrent therapy in 58.2% of patients. Clinical success was observed in 82.6% (19/23) of patients treated with CPT-F as monotherapy. In patients treated with CPT-F as first-line therapy or second-line or later therapy, 75.0% (3/4) and 70.6% (36/51) achieved success, respectively. Clinical success was observed in 77.3% (34/44) of patients with MRSA and 25% (1/4) of patients with MSSA. Two patients discontinued treatment with CPT-F due to an adverse event.Conclusions
CPT-F treatment was associated with a high rate of clinical success in patients with Gram-positive infective endocarditis, including those with risk factors and infections caused by MRSA. A high rate of clinical success was observed in patients treated with CPT-F used as first- line therapy or second-line or later therapy, or as monotherapy or in combination with other antibiotics. 相似文献10.